Ippei Sakamaki
- Immunology top 10%
- Infectious Diseases top 5%
- Molecular Biology
- Oncology
- Epidemiology
- Co-authors
- Hong QinLarry W. KwakYoshihiro YamamotoHitoshi KawasujiAkitoshi UenoYuki MiyajimaQing YiGuo‐Wei Wei
- Topics
- SARS-CoV-2 and COVID-19 Research (11 papers)COVID-19 Clinical Research Studies (11 papers)Immunotherapy and Immune Responses (7 papers)
- Journals
- Nature MedicineBloodPLoS ONE
- Partner nations
- JapanUnited StatesVietnam
In The Last Decade
Ippei Sakamaki
42 papers receiving 739 citations
Peers
Comparison fields: 5 of 88
- Immunology 293
- Infectious Diseases 261
- Molecular Biology 171
- Oncology 170
- Epidemiology 79
Countries citing papers authored by Ippei Sakamaki
This map shows the geographic impact of Ippei Sakamaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ippei Sakamaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ippei Sakamaki more than expected).
Fields of papers citing papers by Ippei Sakamaki
This network shows the impact of papers produced by Ippei Sakamaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ippei Sakamaki. The network helps show where Ippei Sakamaki may publish in the future.
Co-authorship network of co-authors of Ippei Sakamaki
This figure shows the co-authorship network connecting the top 25 collaborators of Ippei Sakamaki. A scholar is included among the top collaborators of Ippei Sakamaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ippei Sakamaki. Ippei Sakamaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 37 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 29 | |
| 10 | 93 | |
| 11 | 4 | |
| 12 | 7 | |
| 13 | 8 | |
| 14 | 24 | |
| 15 | 189 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 0 | |
| 19 | 7 | |
| 20 | 1 |
About Ippei Sakamaki
Ippei Sakamaki is a scholar working on Infectious Diseases, Microbiology and Neurology, having authored 48 papers that have together received 746 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (11 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Infectious Diseases (261 citations), Immunology (293 citations) and Clinical Biochemistry (44 citations). Ippei Sakamaki has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Hong Qin, Larry W. Kwak, Yoshihiro Yamamoto, Hitoshi Kawasuji, Akitoshi Ueno, Yuki Miyajima, Qing Yi, Guo‐Wei Wei, Karen C. Dwyer and Yared Hailemichael. Their work appears in journals such as Nature Medicine, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.